78 related articles for article (PubMed ID: 11494336)
1. Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines.
Stratton MS; Sirvent H; Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2001 Aug; 48(3):206-9. PubMed ID: 11494336
[TBL] [Abstract][Full Text] [Related]
2. Androgens block interleukin-1 beta-induced promatrilysin expression in prostate carcinoma cells.
Stratton MS; Greenstein B; Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2002 Sep; 53(1):1-8. PubMed ID: 12210475
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
Udayakumar TS; Bair EL; Nagle RB; Bowden GT
Mol Carcinog; 2003 Oct; 38(2):70-7. PubMed ID: 14502646
[TBL] [Abstract][Full Text] [Related]
4. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
[TBL] [Abstract][Full Text] [Related]
6. Integrin- and cadherin-mediated induction of the matrix metalloprotease matrilysin in cocultures of malignant oral squamous cell carcinoma cells and dermal fibroblasts.
Bair EL; Massey CP; Tran NL; Borchers AH; Heimark RL; Cress AE; Bowden GT
Exp Cell Res; 2001 Nov; 270(2):259-67. PubMed ID: 11640889
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1998; 18(6A):4403-8. PubMed ID: 9891500
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
9. mRNA expression of the five membrane-type matrix metalloproteinases MT1-MT5 in human prostatic cell lines and their down-regulation in human malignant prostatic tissue.
Jung M; Römer A; Keyszer G; Lein M; Kristiansen G; Schnorr D; Loening SA; Jung K
Prostate; 2003 May; 55(2):89-98. PubMed ID: 12661033
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP.
Maliner-Stratton MS; Klein RD; Udayakumar TS; Nagle RB; Bowden GT
Neoplasia; 2001; 3(6):509-20. PubMed ID: 11774033
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway.
Lee SO; Lou W; Johnson CS; Trump DL; Gao AC
Prostate; 2004 Aug; 60(3):178-86. PubMed ID: 15176047
[TBL] [Abstract][Full Text] [Related]
13. Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.
Vayalil PK; Katiyar SK
Prostate; 2004 Apr; 59(1):33-42. PubMed ID: 14991864
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
16. [Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials].
Zhang LL; He DL; Li X; Li L; Zhu GD; Wang XY
Zhonghua Nan Ke Xue; 2006 Oct; 12(10):913-6. PubMed ID: 17121023
[TBL] [Abstract][Full Text] [Related]
17. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
18. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model.
Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR
Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
Kooijman R; Himpe E; Potikanond S; Coppens A
Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
[TBL] [Abstract][Full Text] [Related]
20. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
